Project Details
Description
Retrospective non-interventional study (NIS) that aims to describe the demographics, clinical characteristics, clinical outcomes, and treatment patterns, among patients receiving palbociclib for the treatment of HR+/HER2- metastatic/locally advanced breast cancer (BC).
| Status | Finished |
|---|---|
| Effective start/end date | 13/09/21 → 27/12/22 |
Collaborative partners
- Pfizer (lead)
- Mediclinic City Hospital
- Dubai Hospital
- Tawam Hospital
- Abu Dhabi Health Services Company
Keywords
- Retrospective Studies
- Palbociclib
- Neoplasms by Site
- Neoplasms
- Breast Diseases
- Skin Diseases
- Breast Neoplasms
- Hormonal Antineoplastic Agents
- Antineoplastic Agents
- Estrogen Receptor Antagonists
- Estrogen Antagonists
- Hormone Antagonists
- Hormones
- Hormone Substitutes
- Physiological Effects of Drugs
- Protein Kinase Inhibitors
- Enzyme Inhibitors
- Molecular Mechanisms of Pharmacological Action
- Steroid Synthesis Inhibitors
- Fulvestrant
- Aromatase Inhibitors
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.